AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 33989351 — intervention group
Group type: COMPARATOR
Intervention: Palpation method
Number of subjects: 256
Study 35946062 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture (High Expectancy)
Number of subjects: 0
Study 35946062 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture (Low Expectancy)
Number of subjects: 0
Study 35946062 — intervention group
Group type: EXPERIMENTAL
Intervention: Sham Acupuncture (High Expectancy)
Number of subjects: 0
Study 35946062 — intervention group
Group type: EXPERIMENTAL
Intervention: Sham Acupuncture (Low Expectancy)
Number of subjects: 0
Study 33237254 — intervention group
Group type: EXPERIMENTAL
Intervention: #Tamojunto school‐based drug prevention program
Number of subjects: 6391
Study 33237254 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline behavior problems
Number of subjects: 6391
Study 33237254 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline alcohol use
Number of subjects: 6391
Study 33237254 — intervention group
Group type: EXPERIMENTAL
Intervention: Female gender
Number of subjects: 6391
Study 33107226 — intervention group
Group type: EXPERIMENTAL
Intervention: Novel endoscopic criteria for predicting tumor invasion depth in SESC
Number of subjects: 352
Study 33107226 — intervention group
Group type: COMPARATOR
Intervention: Endoscopically mucosal vs submucosal cancers
Number of subjects: 352
Study 33930187 — intervention group
Group type: EXPERIMENTAL
Intervention: Foley catheter with 500 ml weight attached
Number of subjects: 399
Study 33930187 — intervention group
Group type: COMPARATOR
Intervention: Foley catheter without weight attached
Number of subjects: 399
Study 33675423 — intervention group
Group type: EXPERIMENTAL
Intervention: Concentric cycling (CONC-M: 50% maximum concentric cycling power output)
Number of subjects: 10
Study 33675423 — intervention group
Group type: EXPERIMENTAL
Intervention: Eccentric cycling (ECC-M: 50% POmax)
Number of subjects: 10
Study 33675423 — intervention group
Group type: EXPERIMENTAL
Intervention: High-intensity eccentric cycling (ECC-H: 100% POmax)
Number of subjects: 10
Study 33675423 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 10
Study 32672798 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjuvant systemic chemotherapy
Number of subjects: 393
Study 32672798 — intervention group
Group type: COMPARATOR
Intervention: Active surveillance
Number of subjects: 393
Study 34709347 — intervention group
Group type: EXPERIMENTAL
Intervention: Geographic atrophy (GA)
Number of subjects: 237
Study 34709347 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline GA area
Number of subjects: 237
Study 34709347 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline GA perimeter
Number of subjects: 237
Study 34709347 — intervention group
Group type: EXPERIMENTAL
Intervention: Lesion number
Number of subjects: 237
Study 34709347 — intervention group
Group type: EXPERIMENTAL
Intervention: Circularity index
Number of subjects: 237
Study 34709347 — intervention group
Group type: EXPERIMENTAL
Intervention: Retinal eccentricity
Number of subjects: 237
Study 34709347 — intervention group
Group type: EXPERIMENTAL
Intervention: Percentage area affected by GA
Number of subjects: 237
Study 32305259 — intervention group
Group type: EXPERIMENTAL
Intervention: Mifepristone-misoprostol
Number of subjects: 297
Study 32305259 — intervention group
Group type: COMPARATOR
Intervention: Misoprostol alone
Number of subjects: 297
Study 32305259 — intervention group
Group type: EXPERIMENTAL
Intervention: Mifepristone treatment
Number of subjects: 297
Study 32305259 — intervention group
Group type: EXPERIMENTAL
Intervention: Smoking
Number of subjects: 297
Study 35442432 — intervention group
Group type: EXPERIMENTAL
Intervention: SHUTi (standard internet-delivered CBT-I)
Number of subjects: 333
Study 35442432 — intervention group
Group type: EXPERIMENTAL
Intervention: SHUTi-BWHS (culturally tailored internet-delivered CBT-I)
Number of subjects: 333
Study 35442432 — intervention group
Group type: COMPARATOR
Intervention: PE (patient education about sleep)
Number of subjects: 333
Study 35442432 — intervention group
Group type: EXPERIMENTAL
Intervention: SHUTi-BWHS
Number of subjects: 333
Study 35442432 — intervention group
Group type: EXPERIMENTAL
Intervention: SHUTi and SHUTi-BWHS (combined)
Number of subjects: 333
Study 32048365 — intervention group
Group type: EXPERIMENTAL
Intervention: Saffron supplement (100 mg/day)
Number of subjects: 66
Study 35238652 — intervention group
Group type: EXPERIMENTAL
Intervention: MuIS+ (n=24)
Number of subjects: 70
Study 35238652 — intervention group
Group type: COMPARATOR
Intervention: Surgical limb (SX)
Number of subjects: 70
Study 34059274 — intervention group
Group type: EXPERIMENTAL
Intervention: 1.5% dipotassium oxalate monohydrate (KOX) oral rinse
Number of subjects: 89
Study 34059274 — intervention group
Group type: COMPARATOR
Intervention: Placebo oral rinse
Number of subjects: 89
Study 34059274 — intervention group
Group type: COMPARATOR
Intervention: Negative Control oral rinse
Number of subjects: 89
Study 33878350 — intervention group
Group type: EXPERIMENTAL
Intervention: Warning topics (text‐only, icon, graphic)
Number of subjects: 1078
Study 33878350 — intervention group
Group type: EXPERIMENTAL
Intervention: Icon warnings
Number of subjects: 1078
Study 33878350 — intervention group
Group type: EXPERIMENTAL
Intervention: Graphic warnings
Number of subjects: 1078
Study 32087011 — intervention group
Group type: EXPERIMENTAL
Intervention: Shiny CRT Calculator
Number of subjects: 0
Study 32087011 — intervention group
Group type: EXPERIMENTAL
Intervention: Cluster randomized designs
Number of subjects: 0
Study 32087011 — intervention group
Group type: EXPERIMENTAL
Intervention: Cross-sectional and cohort designs
Number of subjects: 0
Study 36140138 — intervention group
Group type: EXPERIMENTAL
Intervention: Convolutional Neural Network (CNN) based AD diagnosis using surface-enhanced Raman spectroscopy (SERS) fingerprints of human cerebrospinal fluid (CSF)
Number of subjects: 0
Study 33559538 — intervention group
Group type: EXPERIMENTAL
Intervention: Secure prime condition
Number of subjects: 154
Study 33559538 — intervention group
Group type: COMPARATOR
Intervention: Neutral prime condition
Number of subjects: 154
Study 33027722 — intervention group
Group type: EXPERIMENTAL
Intervention: Hysteroscopic injection (HI)
Number of subjects: 151
Study 33027722 — intervention group
Group type: COMPARATOR
Intervention: Cervical injection (CI)
Number of subjects: 151
Study 35064823 — intervention group
Group type: EXPERIMENTAL
Intervention: Prophylactic long-acting G-CSF
Number of subjects: 68
Study 35064823 — intervention group
Group type: COMPARATOR
Intervention: Prophylactic standard G-CSF
Number of subjects: 68
Study 32135042 — intervention group
Group type: EXPERIMENTAL
Intervention: Antistigma intervention curriculum (ASIC)
Number of subjects: 220
Study 32135042 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 220
Study 35139070 — intervention group
Group type: EXPERIMENTAL
Intervention: IDA (ivermectin, diethylcarbamazine, and albendazole)
Number of subjects: 4563
Study 35139070 — intervention group
Group type: COMPARATOR
Intervention: DA (diethylcarbamazine and albendazole)
Number of subjects: 4563
Study 35139070 — intervention group
Group type: EXPERIMENTAL
Intervention: IDA
Number of subjects: 4563
Study 35139070 — intervention group
Group type: COMPARATOR
Intervention: DA
Number of subjects: 4563
Study 33672908 — intervention group
Group type: EXPERIMENTAL
Intervention: Crossover turn
Number of subjects: 18
Study 33672908 — intervention group
Group type: EXPERIMENTAL
Intervention: Somersault turn
Number of subjects: 18
Study 33672908 — intervention group
Group type: COMPARATOR
Intervention: All turning techniques
Number of subjects: 18
Study 35732385 — intervention group
Group type: EXPERIMENTAL
Intervention: Intramuscular midazolam (0.05 mg/kg)
Number of subjects: 134
Study 35732385 — intervention group
Group type: COMPARATOR
Intervention: Placebo (normal saline 0.01 mL/kg)
Number of subjects: 134
Study 33121474 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous propofol (10 ml propofol with 1 ml 2% lidocaine), 0.5‐1 mg/kg before endotracheal suctioning
Number of subjects: 208
Study 33121474 — intervention group
Group type: COMPARATOR
Intervention: Control group (endotracheal suctioning only)
Number of subjects: 208
Study 33121474 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous propofol
Number of subjects: 208
Study 32627619 — intervention group
Group type: EXPERIMENTAL
Intervention: Transoral CO2 laser therapy
Number of subjects: 40
Study 33218508 — intervention group
Group type: EXPERIMENTAL
Intervention: Pilates Matwork exercises (50 min, twice a week for 4 months)
Number of subjects: 40
Study 33218508 — intervention group
Group type: COMPARATOR
Intervention: Control Group (no intervention)
Number of subjects: 40
Study 34170371 — intervention group
Group type: EXPERIMENTAL
Intervention: Procollagen type I C‐terminal pro‐peptide (PICP)
Number of subjects: 2773
Study 34170371 — intervention group
Group type: EXPERIMENTAL
Intervention: Galectin‐3 (Gal‐3)
Number of subjects: 2773
Study 34170371 — intervention group
Group type: EXPERIMENTAL
Intervention: PICP and Gal‐3 interaction
Number of subjects: 2773
Study 34170371 — intervention group
Group type: EXPERIMENTAL
Intervention: PICP, Gal‐3 and their interaction
Number of subjects: 2773
Study 32286005 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient-targeted feedback intervention after depression screening using the Patient Health Questionnaire (PHQ-9)
Number of subjects: 12
Study 32286005 — intervention group
Group type: EXPERIMENTAL
Intervention: Workshops conducted with patients
Number of subjects: 12
Study 32286005 — intervention group
Group type: EXPERIMENTAL
Intervention: Public and Patient Engagement Evaluation Tools (PPEET)
Number of subjects: 12
Study 35897363 — intervention group
Group type: EXPERIMENTAL
Intervention: 38% Silver Diamine Fluoride (SDF)
Number of subjects: 290
Study 35897363 — intervention group
Group type: COMPARATOR
Intervention: 5% Sodium Fluoride (NaF) varnish
Number of subjects: 290
Study 33977744 — intervention group
Group type: EXPERIMENTAL
Intervention: Above-knee lateral approach (Group L)
Number of subjects: 53
Study 33977744 — intervention group
Group type: COMPARATOR
Intervention: Anterior approach (Group A)
Number of subjects: 53
Study 32419378 — intervention group
Group type: EXPERIMENTAL
Intervention: Healthy diet (low in carbohydrates, rich in omega-3 fatty acids, vitamins C and D, antioxidants, and fiber)
Number of subjects: 14
Study 32419378 — intervention group
Group type: COMPARATOR
Intervention: Standard diet (high in processed carbohydrates)
Number of subjects: 14
Study 34535300 — intervention group
Group type: EXPERIMENTAL
Intervention: Fixed dose of 1000 IU of 4F-PCC
Number of subjects: 199
Study 34535300 — intervention group
Group type: COMPARATOR
Intervention: Variable dosing of 4F-PCC
Number of subjects: 199
Study 33625393 — intervention group
Group type: EXPERIMENTAL
Intervention: 3-unit fiber-reinforced RBFDPs
Number of subjects: 50
Study 33625393 — intervention group
Group type: COMPARATOR
Intervention: 3-unit metal-ceramic RBFDPs
Number of subjects: 50
Study 33625393 — intervention group
Group type: COMPARATOR
Intervention: 2-unit cantilevered metal-ceramic RBFDPs
Number of subjects: 50
Study 32902644 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise Training (ET) for 4 months
Number of subjects: 55
Study 32902644 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise Training (ET) with omega-3 supplementation (Calanus oil) for 4 months
Number of subjects: 55
Study 32902644 — intervention group
Group type: COMPARATOR
Intervention: Physically active/fit (trained)
Number of subjects: 55
Study 32902644 — intervention group
Group type: COMPARATOR
Intervention: Sedentary/less physically fit (untrained)
Number of subjects: 55
Study 34023889 — intervention group
Group type: EXPERIMENTAL
Intervention: Genetic predisposition to AF
Number of subjects: 588190
Study 34023889 — intervention group
Group type: EXPERIMENTAL
Intervention: Allele score for AF
Number of subjects: 588190
Study 34023889 — intervention group
Group type: COMPARATOR
Intervention: Genetically predicted eGFR
Number of subjects: 588190
Study 34023889 — intervention group
Group type: COMPARATOR
Intervention: Allele score for eGFR
Number of subjects: 588190
Study 33398869 — intervention group
Group type: EXPERIMENTAL
Intervention: Thoracic paravertebral block (TPVB) performed unilaterally at T6 before surgery
Number of subjects: 78
Study 33398869 — intervention group
Group type: COMPARATOR
Intervention: General anesthesia
Number of subjects: 78
Study 36078048 — intervention group
Group type: EXPERIMENTAL
Intervention: Clonidine 150 μg
Number of subjects: 12
Study 36078048 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 33878338 — intervention group
Group type: EXPERIMENTAL
Intervention: Dapagliflozin 10mg
Number of subjects: 270
Study 33878338 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 270
Study 36113085 — intervention group
Group type: EXPERIMENTAL
Intervention: Avatrombopag
Number of subjects: 0
Study 36113085 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 34537006 — intervention group
Group type: EXPERIMENTAL
Intervention: Erenumab 70 mg
Number of subjects: 261
Study 34537006 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 261
Study 36092193 — intervention group
Group type: EXPERIMENTAL
Intervention: Bacillus clausii (Strains O/C, N/R, SIN and T) suspension available as Enterogermina® at the dose of 2 billion spores/5 ml twice daily for 8 weeks along with conventional treatment.
Number of subjects: 114
Study 36092193 — intervention group
Group type: COMPARATOR
Intervention: Conventional treatment only.
Number of subjects: 114
Study 36092193 — intervention group
Group type: EXPERIMENTAL
Intervention: Bacillus clausii supplementation along with conventional treatment.
Number of subjects: 114
Study 34233966 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotic and egg oral immunotherapy (OIT) administered once daily for 18 months
Number of subjects: 80
Study 34233966 — intervention group
Group type: COMPARATOR
Intervention: Placebo administered once daily for 18 months
Number of subjects: 80
Study 35525625 — intervention group
Group type: COMPARATOR
Intervention: Control group (n=14) - cast-free digital workflow
Number of subjects: 28
Study 35525625 — intervention group
Group type: EXPERIMENTAL
Intervention: Test group (n=14) - partially digital workflow
Number of subjects: 28
Study 35525625 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 28
Study 33083816 — intervention group
Group type: EXPERIMENTAL
Intervention: Spot urine samples
Number of subjects: 24
Study 33083816 — intervention group
Group type: COMPARATOR
Intervention: 24-hour urine samples
Number of subjects: 24
Study 35726287 — intervention group
Group type: EXPERIMENTAL
Intervention: Artificial intelligence FCM algorithm for MRI diagnosis
Number of subjects: 116
Study 35726287 — intervention group
Group type: EXPERIMENTAL
Intervention: Comprehensive nursing intervention
Number of subjects: 116
Study 35726287 — intervention group
Group type: COMPARATOR
Intervention: Routine nursing (Control)
Number of subjects: 116
Study 35726287 — intervention group
Group type: COMPARATOR
Intervention: Postoperative adverse reactions (Control)
Number of subjects: 116
Study 35726287 — intervention group
Group type: EXPERIMENTAL
Intervention: Postoperative adverse reactions (Experimental)
Number of subjects: 116
Study 33113161 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyoscine‐N‐butylbromide 20 mg (1 mL)
Number of subjects: 126
Study 33113161 — intervention group
Group type: COMPARATOR
Intervention: Sterile water (1 mL)
Number of subjects: 126
Study 616707197 — intervention group
Group type: EXPERIMENTAL
Intervention: Computer-assisted safer sex intervention delivered through three individual sessions tailored to participants' needs, incorporating elements of motivational interviewing and cognitive-behavioral therapy.
Number of subjects: 0
Study 616707197 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified in the abstract.
Number of subjects: 0
Study 33231281 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketorolac group (50 mg bupivacaine + 30 mg ketorolac)
Number of subjects: 54
Study 33231281 — intervention group
Group type: COMPARATOR
Intervention: Bupivacaine group (50 mg bupivacaine)
Number of subjects: 54
Study 34537835 — intervention group
Group type: EXPERIMENTAL
Intervention: CoronaVac vaccine
Number of subjects: 434
Study 34537835 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 434
Study 32502775 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound-guided lumbar plexus block (LPB)
Number of subjects: 60
Study 32502775 — intervention group
Group type: EXPERIMENTAL
Intervention: Suprainguinal fascia iliaca block (SIFIB)
Number of subjects: 60
Study 35470300 — intervention group
Group type: EXPERIMENTAL
Intervention: Aggressive Hydration (vHR) with lactated Ringer's solution (3 mL/kg/h during procedure, 20 ml/kg bolus immediately afterward, then 3 mL/kg/h for another 8 hours)
Number of subjects: 352
Study 35470300 — intervention group
Group type: COMPARATOR
Intervention: High-dose Rectal Indomethacin (100 mg suppository immediately post-ERCP)
Number of subjects: 352
Study 34258265 — intervention group
Group type: EXPERIMENTAL
Intervention: Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy (CRS+HIPEC)
Number of subjects: 100
Study 614031389 — intervention group
Group type: EXPERIMENTAL
Intervention: TPB‐based intervention program delivered during 6 weeks postpartum
Number of subjects: 285
Study 614031389 — intervention group
Group type: EXPERIMENTAL
Intervention: TPB‐based intervention program
Number of subjects: 285
Study 614031389 — intervention group
Group type: COMPARATOR
Intervention: Standard obstetric care (Control)
Number of subjects: 285
Study 35736027 — intervention group
Group type: EXPERIMENTAL
Intervention: Lasmiditan
Number of subjects: 846
Study 35736027 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 846
Study 32534083 — intervention group
Group type: EXPERIMENTAL
Intervention: Dermoscopic reticular pattern
Number of subjects: 112
Study 32534083 — intervention group
Group type: EXPERIMENTAL
Intervention: Dermoscopic globular pattern
Number of subjects: 112
Study 32534083 — intervention group
Group type: EXPERIMENTAL
Intervention: Dermoscopic complex pattern
Number of subjects: 112
Study 32534083 — intervention group
Group type: EXPERIMENTAL
Intervention: Dermoscopic homogenous pattern
Number of subjects: 112
Study 32534083 — intervention group
Group type: EXPERIMENTAL
Intervention: Dermoscopic clinical regression model
Number of subjects: 112
Study 32987359 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline Montreal Cognitive Assessment (MoCA) memory performance
Number of subjects: 324
Study 32987359 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline MoCA memory
Number of subjects: 324
Study 32987359 — intervention group
Group type: EXPERIMENTAL
Intervention: Increasing subjective cognitive complaints in Neuro‐QoL‐EF
Number of subjects: 324
Study 32987359 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline depression and anticholinergic use
Number of subjects: 324
Study 36325678 — intervention group
Group type: EXPERIMENTAL
Intervention: Onabotulinumtoxin-A (treatment)
Number of subjects: 0
Study 36325678 — intervention group
Group type: COMPARATOR
Intervention: 0.9% sodium-chloride solution (placebo)
Number of subjects: 0
Study 33421863 — intervention group
Group type: EXPERIMENTAL
Intervention: Smartphone-based monitoring and treatment system
Number of subjects: 120
Study 33421863 — intervention group
Group type: COMPARATOR
Intervention: Standard treatment
Number of subjects: 120
Study 34302282 — intervention group
Group type: EXPERIMENTAL
Intervention: Community-based sexual and reproductive health services (HTS)
Number of subjects: 5757
Study 34302282 — intervention group
Group type: EXPERIMENTAL
Intervention: Community-based hubs for HIV testing
Number of subjects: 5757
Study 34357493 — intervention group
Group type: EXPERIMENTAL
Intervention: Neoadjuvant letrozole and exemestane given sequentially for at least 4 months
Number of subjects: 50
Study 34357493 — intervention group
Group type: EXPERIMENTAL
Intervention: Type II MRI pattern (fragmentation)
Number of subjects: 50
Study 34357493 — intervention group
Group type: EXPERIMENTAL
Intervention: Type IV MRI pattern
Number of subjects: 50
Study 35159340 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive Strength Training (IST: 3×10 reps at 80% 1RM)
Number of subjects: 14
Study 35159340 — intervention group
Group type: EXPERIMENTAL
Intervention: Strength Endurance Training (SET: 2×30 reps at 40% 1RM)
Number of subjects: 14
Study 35159340 — intervention group
Group type: COMPARATOR
Intervention: Control (CON: 3×30 sec stretching)
Number of subjects: 14
Study 34403280 — intervention group
Group type: EXPERIMENTAL
Intervention: Pretrial cue to target location with three-voice masker
Number of subjects: 0
Study 34403280 — intervention group
Group type: EXPERIMENTAL
Intervention: Location-unknown condition with three-voice masker
Number of subjects: 0
Study 34403280 — intervention group
Group type: COMPARATOR
Intervention: One-voice masker
Number of subjects: 0
Study 34403280 — intervention group
Group type: COMPARATOR
Intervention: Noise-burst masker
Number of subjects: 0
Study 33768245 — intervention group
Group type: EXPERIMENTAL
Intervention: Levcromakalim (0.05 mg/min infusion)
Number of subjects: 17
Study 33768245 — intervention group
Group type: COMPARATOR
Intervention: Placebo (isotonic saline)
Number of subjects: 17
Study 33215889 — intervention group
Group type: EXPERIMENTAL
Intervention: Low Amplitude Seizure Therapy (LAP-ST)
Number of subjects: 11
Study 33215889 — intervention group
Group type: COMPARATOR
Intervention: Standard Right Unilateral Electroconvulsive Therapy (RUL ECT)
Number of subjects: 11
Study 35640205 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention practices with patient enrolment, longer appointments, and early post-hospital follow-up.
Number of subjects: 774
Study 35640205 — intervention group
Group type: COMPARATOR
Intervention: Control practices without the intervention.
Number of subjects: 774
Study 35640205 — intervention group
Group type: EXPERIMENTAL
Intervention: Both intervention and control groups.
Number of subjects: 774
Study 34825102 — intervention group
Group type: EXPERIMENTAL
Intervention: Community advertising (newspapers)
Number of subjects: 0
Study 34825102 — intervention group
Group type: EXPERIMENTAL
Intervention: Social media (Craigslist)
Number of subjects: 0
Study 34825102 — intervention group
Group type: EXPERIMENTAL
Intervention: Social media (Facebook and LinkedIn)
Number of subjects: 0
Study 34825102 — intervention group
Group type: EXPERIMENTAL
Intervention: General recruitment efforts
Number of subjects: 0
Study 34850952 — intervention group
Group type: EXPERIMENTAL
Intervention: DMARD treatment (increased from 17% in 1993-1997 to 52% in 2015-2019)
Number of subjects: 1132
Study 34850952 — intervention group
Group type: EXPERIMENTAL
Intervention: DMARD treatment
Number of subjects: 1132
Study 33769862 — intervention group
Group type: EXPERIMENTAL
Intervention: Ribociclib (RIB)
Number of subjects: 1160